17 results
Phosphate binders - quick reference chart of maximum daily dose. Most patients with CKD will require
maximum daily dose ... patients with CKD ... phosphate binding agents ... Purposes Only* #CKD ... #Dosing #Pharmacology
Algorithm for Metformin Prescribing and Dosing in CKD
Dose Initiation - Immediate release:
 • Initial 500 mg
Algorithm for Metformin ... Prescribing and Dosing ... in CKD Dose Initiation ... #Prescribing #Dosing ... #CKD #pharmacology
Treatment of Stable Narrow-Complex Tachycardia
Regular Rhythm:
 • Attempt vagal maneuvers
 • Give adenosine 6 milligrams IV
nodal blocking agents ... Treat underlying cause ... Treat underlying cause ... Treatment #management #cardiology ... #algorithm
Primary and Secondary Causes of Hypertension - Differential Diagnosis Algorithm
Primary (Essential) (95%) - Onset between age
Hypertension - Differential ... Diagnosis Algorithm ... , work or when using ... parenchymal disease - CKD ... Secondary #HTN #Cardiology
Potassium-Binding Agents to Treat Hyperkalemia
Sodium zirconium cyclosilicate (Lokelma):
 • Mechanism: Preferentially captures K in exchange for
Potassium-Binding Agents ... and sodium • Dosing ... 10 g QD (adjust dose ... g QD; increase dose ... #medications #pharmacology
Causes of Pericarditis - Differential Diagnosis Algorithm
Viral:
 • Coxsackie
 • Echovirus
 • Adenovirus
 • Epstein-Barr virus
Causes of Pericarditis ... - Differential ... Diagnosis Algorithm ... Reactive • Primary CTD ... #Causes #Cardiology
Eczematous Skin Rash - Differential Diagnosis Algorithm
Eczematous - Pruritic/Scaly/Erythematous lesions. Usually poorly demarcated
 • Atopic Dermatitis
Eczematous Skin Rash - Differential ... Diagnosis Algorithm ... requires high doses ... of the agent. ... #causes
Causes of Secondary Hypertension - Workup and Differential Diagnosis
Approach (when evaluation should be done):
1. Severe or
Hypertension - Workup and Differential ... use of adequate doses ... antihypertensive agents ... parenchymal disease: CKD ... #Differential #
Acute Atrial Fibrillation - Initial Options for Rate Control
Diltiazem IV
 •  Rapid onset and rapidly
IV bolus can cause ... • 3rd line agent ... • Does not cause ... Rate #Control #pharmacology ... #management #cardiology
Antiplatelet Conversion - Switching Between Oral P2Y12 Inhibitors
A, Switching between oral agents in the acute/early phase.
Switching between oral agents ... (LD) in most cases ... the timing and dosing ... Switching between oral agents ... ticagrelor #prasugrel #pharmacology